sameAs
Endomucin prevents leukocyte-endothelial cell adhesion and has a critical role under resting and inflammatory conditions.Soluble endoglin contributes to the pathogenesis of preeclampsiaImpaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188Oxidized Lipoprotein Uptake Through the CD36 Receptor Activates the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells.Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptorsTGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature.Neuropilin 1 expression correlates with differentiation status of epidermal cells and cutaneous squamous cell carcinomas.Tamoxifen toxicity in cultured retinal pigment epithelial cells is mediated by concurrent regulated cell death mechanisms.Notch signaling functions in retinal pericyte survivalRhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis.Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environmentTranscriptional regulation of vascular endothelial growth factor in cancer.Engineering vascularized skeletal muscle tissue.Blood vessel maturation: vascular development comes of ageJudah Folkman's contribution to the inhibition of angiogenesis.Vascular endothelial growth factor localization in the adult.Vascular endothelial growth factor (VEGF) isoform regulation of early forebrain development.Expression and role of VEGF in the adult retinal pigment epitheliumDecreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing.Role of shear-stress-induced VEGF expression in endothelial cell survivalDevelopment and pathology of the hyaloid, choroidal and retinal vasculature.Roles for VEGF in the adult.Regulation of soluble neuropilin 1, an endogenous angiogenesis inhibitor, in liver development and regeneration.VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization.Expression and role of VEGF--a in the ciliary body.Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiationNLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degenerationIGF2: epigenetic regulation and role in development and disease.Transcriptional repression of VEGF by ZNF24: mechanistic studies and vascular consequences in vivo.Neuropilin 1 Receptor Is Up-Regulated in Dysplastic Epithelium and Oral Squamous Cell Carcinoma.What tangled webs they weave: Rho-GTPase control of angiogenesis.Vascular endothelial growth factor is important for brown adipose tissue development and maintenance.Epoxyeicosanoids promote organ and tissue regeneration.Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases.Revisiting the mouse model of oxygen-induced retinopathy.Arterial versus venous endothelial cells.Inhibition of VEGF or TGF-{beta} signaling activates endothelium and increases leukocyte rolling.Editing VEGFR2 Blocks VEGF-Induced Activation of Akt and Tube Formation.A brief history of anti-VEGF for the treatment of ocular angiogenesis.Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
P50
Q27335094-51B04368-44C5-4BA0-B501-1B22044B5283Q28244053-B9C85161-3807-4388-B466-1C19CAFD878EQ28507115-E104476D-7F99-40DD-A83B-FFD1C898FE64Q30981897-F16DC13B-796D-4470-A79F-13C1792B61BEQ33382103-2D73D238-534D-480D-832D-EAFB7AF6B87FQ33425874-073C88D4-D40F-4163-B5CB-846C434B4FF8Q33818805-45FB3B68-6E1D-45A3-8CB1-6AB0BC85561DQ34003273-CAC6D9D5-438D-4261-95DB-7A3E6E12A7C8Q34069973-250F17BB-0730-40AE-BE18-63D1F7446B0AQ34072195-1DF5ED25-6346-4F80-9F28-F1708484FA73Q34268230-350EAD6A-6B92-405E-878E-EAABD3A9CDB4Q34398077-964153BC-CC77-4159-B80A-6AE9A619297AQ34427542-E6164F83-43A0-4749-A92C-B6F015883429Q34489077-3944ADA0-18B0-4057-B89A-C23901A7658EQ34907455-3FFCDA1D-9606-4D4D-9753-78DCC80820D1Q35087955-6E98DF0A-8725-4252-B9CC-DFEDC0ACBEADQ35289571-CAA2B406-E67A-4538-8D63-0033F1C568F8Q35648344-1DE3EB21-18B0-474A-B099-20BEADE843E3Q35691580-2E31B266-BDDD-4AC1-AE9D-CC4660E9CC03Q35851527-C84C4A9C-8253-4F11-AD47-5348E8690101Q35959824-6A0D0145-6DE1-4F2F-BFE3-B76CE1BE197DQ36248647-1C098E03-5567-4BCE-8FFF-2014BF5BF6BEQ36274124-F6D05CF7-B1FE-427F-A434-05002F64E901Q36371399-40EDE3B7-76EE-4AEB-88FF-B1731A9DF3B5Q36383625-0ED27505-AC68-45F8-97ED-039C9B4924B6Q36489148-42F76A61-49FF-459A-B7A8-3C773F08CD99Q36530569-86B677DE-BFC4-4E0A-984C-0F2CB140CECEQ36561897-1D4DC5CD-3555-42EF-B002-1AE58C40760FQ36569678-7211B939-C127-4E78-9534-33F985292C81Q36769616-ED03518F-7DDE-41BF-A3AD-32F47C57BF9CQ36832262-8F1A53AB-7BAE-4E03-9F45-C1093E7C74AEQ37022876-F599FC55-0F2B-4A6E-A6C7-03BC25DB7CB8Q37104034-5D01C5BD-F61B-4A37-98F1-4861E534F0C0Q37152868-E278792C-683D-498A-B8B9-8E045E594297Q37155762-1986B9AD-6BBB-4CFA-94BF-5ED2CC819E80Q37313072-6E7A24A1-B3B7-4730-9FD1-00B6D9E89F57Q37416913-E2203839-8920-4DB4-9075-E6C345AEA146Q37682513-FF981A7C-5CE9-4C2D-8B23-D8D05F254350Q38022991-0DCF3CDA-06AB-412F-B8B1-BFCF2CA682ACQ38324116-6C441846-A585-4C47-A59D-BD9561D54BF3
P50
description
American opthalmologist
@en
hulumtuese
@sq
wetenschapper
@nl
հետազոտող
@hy
name
Patricia A D'Amore
@sl
Patricia D'Amore
@ast
Patricia D'Amore
@en
Patricia D'Amore
@es
Patricia D'Amore
@nl
type
label
Patricia A D'Amore
@sl
Patricia D'Amore
@ast
Patricia D'Amore
@en
Patricia D'Amore
@es
Patricia D'Amore
@nl
altLabel
Patricia A D'Amore
@ast
Patricia A D'Amore
@en
Patricia A D'Amore
@es
prefLabel
Patricia A D'Amore
@sl
Patricia D'Amore
@ast
Patricia D'Amore
@en
Patricia D'Amore
@es
Patricia D'Amore
@nl
P106
P1015
P214
P244
P269
P1015
P1053
G-5660-2017
P21
P213
0000 0000 4390 7463
P214
P244
nb2001050550
P269
P31
P3829
P496
0000-0001-9652-8974
P569
1950-01-01T00:00:00Z